Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 09-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,971 | -36,825 | -12,828 | -8,249 | N/A |
| Depreciation Amortization | 330 | 113 | 469 | 299 | N/A |
| Accounts payable and accrued liabilities | -364 | -447 | N/A | 117 | N/A |
| Other Working Capital | 2,144 | -5,786 | 1,866 | 715 | N/A |
| Other Operating Activity | 26,992 | 24,214 | 409 | 201 | 0 |
| Operating Cash Flow | $-15,869 | $-18,731 | $-10,084 | $-6,917 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -540 | -169 | -1,483 | -1,483 | N/A |
| Purchase Of Investment | -50 | -50 | N/A | 0 | N/A |
| Investing Cash Flow | $-590 | $-219 | $-1,483 | $-1,483 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 0 | N/A | 34 | N/A |
| Other Financing Activity | 150,852 | 151,534 | 35 | 0 | 0 |
| Financing Cash Flow | $150,852 | $151,534 | $35 | $34 | $N/A |
| Beginning Cash Position | 8,188 | 8,188 | 19,720 | 19,721 | N/A |
| End Cash Position | 142,581 | 140,772 | 8,188 | 11,355 | N/A |
| Net Cash Flow | $134,393 | $132,584 | $-11,532 | $-8,366 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,869 | -18,731 | -10,084 | -6,917 | N/A |
| Capital Expenditure | -540 | -169 | N/A | -1,483 | N/A |
| Free Cash Flow | -16,409 | -18,900 | -10,084 | -8,400 | 0 |